#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute on chronic liver failure Plasma cell myeloma refractory Cognitive disorder Porphyria non-acute Germ cell cancer Idiopathic inflammatory myopathy Leber's congenital amaurosis Malignant melanoma MELAS syndrome Epidermolysis bullosa Marginal zone lymphoma Transferrin decreased Neuroendocrine tumour Immune-mediated myasthenia gravis KBG syndrome More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy Retinitis pigmentosa – Basic Information Activated PI3 kinase delta syndrome – Diagnostics Fabry’s disease – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Nephrotic syndrome – Basic Information Primary immunodeficiency syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Basic Information Paraneoplastic neurological syndrome Alveolar rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Asparaginase Fadraciclib Enfortumab Vedotin Fluasterone Clenbuterol Hydrochloride Mometasone Deoxyribonucleic Acid Allogeneic Faecal Microbiota Norepinephrine Ontasameran Dalteparin Sodium Dapansutrile Dolutegravir Sodium Bi 764532 Fludarabine LY4170156 Agomelatine Guanabenz Acetate Semaglutide Anhydrous Cidofovir More therapies…

    Learn about Your Condition

    Breast angiosarcoma metastatic Obsessive-compulsive disorder Soft tissue sarcoma Ichthyosis Tachypnoea Vulvovaginal discomfort Childhood asthma Multiple system atrophy Genital herpes Pulmonary venous thrombosis Lymphocytic lymphoma Optic atrophy Endometrial cancer stage III Endometrial cancer metastatic Multifocal motor neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypersensitivity

  • Standardization of Olea europaea pollen extract for patients with olive pollen allergies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Olea Europaea Pollen Extract
    • Sodium Chloride
    Spain

  • A Study Testing Prolonged versus Single Dose Penicillin Challenge in Patients with Suspected Penicillin Allergy Using Amoxicillin

    Recruiting

    3 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Amoxicillin Trihydrate
    Belgium Denmark

  • Study on the Effectiveness of Dermatophagoides Allergen Extracts and Histamine Dihydrochloride for Patients with Allergies

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Dermatophagoides Farinae
    • Dermatophagoides Pteronyssinus
    • Histamine Dihydrochloride
    Spain

  • Study on the Effectiveness of Dermatophagoides Allergen Extracts for Allergy Patients Using Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Solutions

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Dermatophagoides Pteronyssinus
    • Histamine Dihydrochloride
    • Sodium Chloride
    Spain

  • Study of Lepidoglyphus destructor allergen extract using skin prick tests in patients with allergies

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Lepidoglyphus Destructor
    • Sodium Chloride
    Spain

  • Evaluation of Blomia tropicalis allergen extract using skin-prick test in patients with allergies

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Blomia Tropicalis
    • Histamine Dihydrochloride
    • Sodium Chloride
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!